Every one of those 1 sits in a single category, fda-approval. Cyclospora cayetanensis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Taylor Farms, all published on August 3, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Taylor Farms
Every one of those 1 sits in a single category, fda-approval. Cyclospora cayetanensis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Taylor Farms, all published on August 3, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Taylor Farms. Shared-story counts are live from our verified record — not editorial picks.
The massive Cyclospora outbreak in Michigan — 11,234 cases — exposes persistent gaps in rapid, sensitive detection and effective antiparasitic therapy, opening opportunities for biotech firms to develop molecular diagnostics and novel treatments for parasitic foodborne illness.